- $1.05bn
- $1.60bn
- $2.55bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.7 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.88 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.41 | ||
| EV to EBITDA | 20.6 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.21% | ||
| Return on Equity | -7.67% | ||
| Operating Margin | -1.58% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 924.64 | 907.96 | 1,352.01 | 1,963.9 | 2,554.74 | 2,070.12 | 2,401.5 | 30.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +46.06 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Directors
- Frank Williams NEC (54)
- Seth Blackley CEO (42)
- John Johnson CFO (37)
- Steve Tutewohl COO (48)
- Aammaad Shams CAO (37)
- Jonathan Weinberg GCN (54)
- Cheryl Scott LED (71)
- David Farner DRC (57)
- Diane Holder DRC (71)
- Craig Barbarosh IND (53)
- M. Bridget Duffy IND (62)
- Peter Grua IND (67)
- Kim Keck IND (57)
- Tunde Sotunde IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 12th, 2014
- Public Since
- June 5th, 2015
- No. of Shareholders
- 77
- No. of Employees
- 4,500
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 116,591,148
- Address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, 22209
- Web
- https://www.evolent.com/
- Phone
- +1 5713896000
- Auditors
- Deloitte & Touche LLP
Upcoming Events for EVH
Q1 2025 Evolent Health Inc Earnings Call
Evolent Health Inc at Needham Technology, Media & Consumer Conference
Evolent Health Inc at RBC Capital Markets Global Healthcare Conference
Evolent Health Inc at William Blair Growth Stock Conference
Evolent Health Inc Annual Shareholders Meeting
Evolent Health Inc Annual Shareholders Meeting
Q2 2025 Evolent Health Inc Earnings Release
Similar to EVH
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
What is the Evolent Health share price?
As of Today at 02:32 UTC, shares in Evolent Health are trading at $8.98. This share price information is delayed by 15 minutes.
How has the Evolent Health share price performed this year?
Shares in Evolent Health last closed at $8.98 and the price had moved by -68.29% over the past 365 days. In terms of relative price strength the Evolent Health share price has underperformed the S&P500 Index by -70.73% over the past year.
What are the analyst and broker recommendations for Evolent Health?
The overall consensus recommendation for Evolent Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Evolent Health dividend yield?
Evolent Health does not currently pay a dividend.
Does Evolent Health pay a dividend?
Evolent Health does not currently pay a dividend.
When does Evolent Health next pay dividends?
Evolent Health does not currently pay a dividend.
How do I buy Evolent Health shares?
To buy shares in Evolent Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Evolent Health?
As of the previous close price of $8.98, shares in Evolent Health had a market capitalisation of $1.05bn.
Where are Evolent Health shares listed?
Here are the trading details for Evolent Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: EVH
What kind of share is Evolent Health?
Based on an overall assessment of its quality, value and momentum Evolent Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Evolent Health share price forecast for 2025?
The analyst consensus target price for shares in Evolent Health is $17.86. That is 98.89% above the last closing price of $8.98.
Analysts covering Evolent Health currently have a consensus Earnings Per Share (EPS) forecast of $0.47 for the next financial year.
Find out moreWhat is the trend in the Evolent Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Evolent Health. Over the past six months, its share price has underperformed the S&P500 Index by -60.6%.
As of the last closing price of $8.98, shares in Evolent Health were trading -47.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Evolent Health PE Ratio?
The Evolent Health PE ratio based on its reported earnings over the past 12 months is 16.7. The shares last closed at $8.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Evolent Health?
Evolent Health's management team is headed by:
- Frank Williams - NEC
- Seth Blackley - CEO
- John Johnson - CFO
- Steve Tutewohl - COO
- Aammaad Shams - CAO
- Jonathan Weinberg - GCN
- Cheryl Scott - LED
- David Farner - DRC
- Diane Holder - DRC
- Craig Barbarosh - IND
- M. Bridget Duffy - IND
- Peter Grua - IND
- Kim Keck - IND
- Tunde Sotunde - IND